Use of alveolar carbon monoxide to measure the effect of ribavirin on red blood cell survival

American Journal of Hematology

Volumn 76, Issue 2, 2004, Pages 107-113

  Virtue, Mark A ^a   Furne, Julie K ^a   Ho, Samuel B ^a   Levitt, Michael D ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Carbon monoxide; Red cell life span; Reticulocytes; Ribavirin

Indexed keywords

CARBON MONOXIDE; RIBAVIRIN;

ADULT; ANEMIA; ARTICLE; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; HEPATITIS C; HUMAN; LUNG DIFFUSION; MALE; PATIENT MONITORING; PRIORITY JOURNAL; RETICULOCYTE;

ADULT; AGED; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; BREATH TESTS; CARBON MONOXIDE; CELL SURVIVAL; ERYTHROCYTES; HEMOGLOBINS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RIBAVIRIN;

EID: 2542563603     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20069     Document Type: Article

References (21)

1. Patterson JL, Fernandez-Larsson R. Molecular mechanisms of action of ribavirin. Rev Infect Dis 1990;12:1132-1146.
2. McHutchinson JG, Gordon SC, Schiff ER, et al. Interferon α-2b alone or in combination with ribavirin as initial treatment of chronic hepatitis C. N Engl J Med 1998;339:1485-1492.
3. Davis GL, Esteban-Mur R, Rustgi V, et al. Interferon α-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med 1998;339:1493-1499.
4. Fattovich G, Giustina G, Defos F, et al. Morbidity and mortality in compensated cirrhosis C: a retrospective follow-up study of 384 patients. Gastroenterology 1997;112:463-472.
5. Bodenheimer HC, Lindsay KL, Davis GL, Lewis JH, Thung SN, Seef LB. Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial. Hepatology 1997;26:437-477.
6. Di Bisceglie AM, Shindo M, Fong TL, et al. Study of ribavirin therapy for chronic hepatitis C. Hepatology 1992;16:649-654.
7. Van Vlierbergh H, Delanghe JR, DeVos M, Leroux-Roel G, BASL Steering Committee. Factors influencing ribavirin-induced hemolysis. J Hepatol 2001;34(6):911-916.
8. Laskin OL, Longstreth HJA, Hart CC, et al. Ribavirin disposition in high-risk patients for acquired immunodeficiency syndrome. Clin Pharmacol Ther 1987;41:546-555.
9. De Franceschi L, Fattovich G, Turrini F, et al. Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage. Hepatology 2000;31:997-1003.
10. Furne J, Springfield J, Ho S, Levitt MD. Simplification of the end-alveolar carbon monoxide technique to assess erythrocyte survival. J Lab Clin Med 2003;142:52-57.
11. Strocchi A, Schwartz S, Ellefson M, Engel RR, Medina A, Levitt MD. A simple carbon monoxide breath test to estimate erythrocyte turnover. J Lab Clin Med 1992;120:392-399.
12. Penner JA. Investigation of erythrocyte turnover with selenium 75-labeled methionine. J Lab Clin Med 1966;67:427-438.
13. Shemin D, Rittenberg D. The life span of the human red blood cell. J Biol Chem 1946;166:627-636.
14. Ebaugh FJ Jr, Emerson CP, Rose JF. The use of radioactive chromium 51 as an erythrocyte-tagging agent for the determination of red cell survival in vivo. J Clin Invest 1953;32:1260-1276.
15. Ricketts C, Cavil I, Napier JA. The measurement of red cell lifespan using (59)Fe. Br J Hematol 1977;37(3):403-408.
16. Landaw SA, Callahan EW, Schmid R. Catabolism of heme in vivo. J Clin Invest 1970;49:914-925.
17. Coburn RF, Blakemore WS, Forster RE. Endogenous carbon monoxide production in man. J Clin Invest 1963;42:1172-1178.
18. Coburn RF, Williams WJ, Kahn SB. Endogenous carbon monoxide production in patients with hemolytic anemia. J Clin Invest 1966;45:460-468.
19. Solanki DL, McCurdy PR, Cuttitta FF, Schechter GP. Hemolysis in sickle cell disease as measured by endogenous carbon monoxide production. Am J Clin Pathol 1988;89:221-225.
20. Coltman CA Jr, Dudley GM III. The relationship between endogenous carbon monoxide production and total heme mass in normal and abnormal subjects. Am J Med Sci 1969;258:374-385.
21. Hillman RS, Finch CA. Erythropoiesis: normal and abnormal. Semin Hematol 1967;4:327-329.